Jane Henderson Apogee Therapeutics, Inc. (APGE) insider trading activity

APGE Quotes by TradingView
Shares Held (Direct Ownership) 195K
2.99% 3M change
2.99% 12M change
Total Value Held N/A

Jane Henderson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 04 2025
SELL
Open market or private sale
$112,500 $75.0 p/Share
1,500 Reduced 0.76%
194,871 Common Stock
Nov 25 2025
SELL
Open market or private sale
$105,000 $70.0 p/Share
1,500 Reduced 0.76%
196,371 Common Stock
Nov 14 2025
SELL
Open market or private sale
$130,000 $65.0 p/Share
2,000 Reduced 1.0%
197,871 Common Stock
Nov 11 2025
SELL
Open market or private sale
$60,000 $60.0 p/Share
1,000 Reduced 0.5%
199,871 Common Stock
Aug 23 2024
SELL
Open market or private sale
$289,560 $48.26 p/Share
6,000 Reduced 2.9%
200,871 Common Stock

Also insider at

SESN
Sesen Bio, Inc. Healthcare
Director
ISEE
IVERIC bio, Inc. Healthcare
Director
AKRO
Akero Therapeutics, Inc. Healthcare
ADGI
Adagio Therapeutics, Inc. Healthcare
Chief Financial Officer
CRGX
CARGO Therapeutics, Inc.
JH

Jane Henderson

Chief Financial Officer
Parsippany, NJ

Track Institutional and Insider Activities on APGE

Follow Apogee Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APGE shares.

Notify only if

Insider Trading

Get notified when an Apogee Therapeutics, Inc. insider buys or sells APGE shares.

Notify only if

News

Receive news related to Apogee Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APGE